Severe Hypoglycemia in Diabetes Drug Approved in Europe

  • 📰 Medscape
  • ⏱ Reading Time:
  • 46 sec. here
  • 26 min. at publisher
  • 📊 Quality Score:
  • News: 106%
  • Publisher: 55%

Diabetes Mellitus Type 1 News

Diabetes Mellitus Type I,Type 1 Diabetes,Type 1 DM

Treatment of insulin-induced hypoglycemia with Zegalogue reduced recovery time from severe hypoglycemia, the European Medicines Agency said.

Severe hypoglycemia is defined as having low blood glucose levels that requires assistance from another person to treat. Severe hypoglycemia is a complication that can occur in people with diabetes who takeThe condition can lead to serious problems that require emergency treatment. Symptoms of severe hypoglycemia include confusion and disorientation, convulsions, seizures, intense nightmares while sleeping, loss of consciousness, and coma.

The active substance of Zegalogue is dasiglucagon, a glycogenolytic hormone that increases blood glucose concentration by activating hepatic glucagon receptors. This stimulates glycogen breakdown and promotes the release of glucose from the liver.The EMA's Committee for Medicinal Products for Human Use based its decision on evidence from two studies involving adults and children aged 6 years or older with diabetes.

Results showed that treatment of insulin-induced hypoglycemia with Zegalogue reduced the time required to increase plasma glucose compared with placebo, with a median time to recovery of 10 minutes. More patients experienced plasma glucose recovery with Zegalogue compared with placebo, the CHMP said. All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC. This website also contains material copyrighted by 3rd parties.

Source: Healthcare Press (healthcarepress.net)

Diabetes Mellitus Type I Type 1 Diabetes Type 1 DM T1DM T1D Drug/Treatment Safety Drug Safety Treatment Safety Drug Development Drug Discovery Drug Pipeline Drug Development Pipeline Drug Legislation Drug Registries Drug Registry Drug Regulation Hypoglycemia Europe European Diabetes Mellitus Type 2 Diabetes Mellitus Type Ii Type 2 Diabetes Type 2 DM T2DM

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Food Insecurity Quadruples Severe Hypoglycemia Risk in T2DBoth financial and physical food insecurity increased the risk, but standard questions didn't capture the latter.
Source: Medscape - 🏆 386. / 55 Read more »

Severe Weather Awareness Week: Severe thunderstormsMeteorologist Pat Cavlin explains the difference between a regular thunderstorm and a severe one.
Source: KHOU - 🏆 330. / 59 Read more »

Severe weather timeline shows rounds of severe weather threats in Chicago areaThe Chicago area will be at risk of severe weather on both Tuesday and Wednesday, with all manner of threats possible in the region.
Source: nbcchicago - 🏆 545. / 51 Read more »

Eli Lilly's diabetes drug tirzepatide gets approval in ChinaEli Lilly's diabetes drug tirzepatide gets approval in China
Source: Investingcom - 🏆 450. / 53 Read more »

Diabetes drug Ozempic reduces risk of death from kidney diseaseThe research suggests that Ozempic, commonly used to treat diabetes, may offer significant benefits for individuals with kidney disease.
Source: IntEngineering - 🏆 287. / 63 Read more »

US teen diabetes drug use skyrockets 600%, female young adults leadAs per reports, there has been an alarming rise in diabetes and weight loss drug use among adolescents and young adults.
Source: IntEngineering - 🏆 287. / 63 Read more »